Rep. Cammack's 2024 Ectopic Pregnancy Exposed a Real Problem: Abortion Misinformation in Emergency Rooms

What Happened

In 2024, Rep. Kat Cammack, R-Fla., experienced a life-threatening ectopic pregnancy. She was hemorrhaging. Her approximately 5-week-old baby had no heartbeat. Her doctors described it as "one of the rarest and most dangerous forms of ectopic pregnancy that exists" and warned her of "catastrophic internal bleeding, permanent organ damage, and potential death," according to Cammack's communications director Rafael Struve.

Doctors told her that if she ruptured, the window to save her life could be "measured in minutes."

Then came the detail that turned a private medical crisis into a legislative flashpoint: hospital staff hesitated before administering methotrexate, the standard drug used to treat ectopic pregnancies, because of messaging they had seen from pro-abortion advocacy groups suggesting providers could face prosecution under Florida's abortion law. A nurse showed Cammack the ad.

What Florida Law Actually Says

Florida Statutes Section 390.011 bans abortion after six weeks. It also explicitly states that removing a dead fetus is not classified as an abortion.

The Centers for Disease Control and Prevention defines abortion as an "intervention" intended to "terminate" a pregnancy "that does not result in a live birth" — a definition that explicitly excludes pregnancy loss and ectopic pregnancy treatment.

Struve was direct about where things stand legally: no professional medical organization and no state abortion law classifies treatment for a miscarriage or an ectopic pregnancy as an abortion. The confusion in Cammack's hospital room came not from the law but from advocacy advertising that blurred that line.

The Misinformation Problem

Since the Supreme Court's June 2022 decision in Dobbs v. Jackson Women's Health Organization returned abortion regulation to the states, pro-abortion organizations have run targeted campaigns directed at physicians and hospital staff in states with restrictive abortion laws. Some of those campaigns have framed ectopic pregnancy treatment and miscarriage management as legally ambiguous, even though no enacted state law treats them as such.

The strongest concern from the pro-abortion side deserves a fair hearing: state abortion laws are sometimes vaguely worded, and physicians facing potential criminal liability have in documented cases delayed or declined care while awaiting legal review. The American College of Obstetricians and Gynecologists and other groups have argued that the chilling effect on providers is real, regardless of whether the law technically permits the care. If a doctor fears prosecution, the patient may suffer the consequences of that fear even when the law is on her side.

That concern is legitimate. The relevant question is whether the source of the confusion is the law itself or campaigns that overstate what the law prohibits. In Cammack's case, her own medical team cited an advocacy ad, not a legal opinion or a state prosecution, as the reason for their hesitation.

The Legislation

Cammack responded to her experience by introducing the Truth in Women's Healthcare Act. According to Struve, the bill is designed to reaffirm accurate medical information and provide clear guidance for emergency departments, patients, lawmakers, and the public.

The bill's specific statutory text was not available in the materials reviewed for this article, so the precise enforcement mechanism and scope remain unclear. What Struve confirmed is that the goal is to prevent the kind of confusion Cammack says she witnessed firsthand: a woman bleeding in an emergency room while her care team second-guesses a treatment that is unambiguously legal.

The Broader Stakes

Cammack's case surfaces a genuine tension in the post-Dobbs landscape. States have the constitutional authority to regulate abortion. Most state laws, including Florida's, include explicit carve-outs for medical emergencies, ectopic pregnancies, and fetal death. But if advocacy campaigns on either side distribute information that misrepresents those carve-outs to frontline medical staff, the consequences reach women in emergency rooms facing delays in critical care.

The video interview that sparked this debate, produced by Tara Palmeri and titled "What Happens When Pro-Life Congresswoman Cammack Needs an Abortion?," framed Cammack's ectopic pregnancy treatment as an "abortion." That framing is medically inaccurate by both the CDC's definition and Florida statutory law, and it is precisely the kind of conflation that Cammack's office says contributed to the delay in her care.

Whether the Truth in Women's Healthcare Act advances in the current Congress and whether its text actually closes the guidance gap in a durable way are the open questions that will determine whether this episode produces any lasting protection for women facing similar emergencies.